Stanitia Davis
Foot & Ankle Surgery · Jackson, MSNPI 1942463567
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Smith+Nephew at 36.9% of the total. Reporting peaked in 2019 at $453 and has fallen 78.6% since, to $97 in 2024.
Across 100 payments — averaging $15.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$565
- Amgen$285
- Cardiovascular Systems Inc.$124
- Convatec Inc.$123
- Organogenesis Inc.$78
- Misonix Inc$49
- plus $304 from 15 others
What the payments were for
- Food & beverage$1,49598%
- Education$342%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 57 | $565 |
| Amgen | 13 | $285 |
| Cardiovascular Systems Inc. | 3 | $124 |
| Convatec Inc. | 5 | $123 |
| Organogenesis Inc. | 3 | $78 |
| Misonix Inc | 3 | $49 |
| Kerecis Limited | 1 | $36 |
| Nabriva Therapeutics, PLC | 1 | $32 |
| Acera Surgical, Inc. | 1 | $32 |
| ALON Medical Technology | 1 | $29 |
| Integra Lifesciences Corporation | 2 | $27 |
| Paragon 28, Inc. | 1 | $22 |
| Averitas Pharma Inc. | 1 | $22 |
| AstraZeneca | 1 | $18 |
| Aroa Biosurgery Incorporated | 1 | $17 |
| Hartmann USA, Inc. | 1 | $16 |
| Melinta Therapeutics, LLC | 1 | $16 |
| Merck | 1 | $13 |
| Bsn Medical Inc | 1 | $12 |
| Hollister Incorporated | 1 | $12 |
| Medline Industries LP | 1 | $0 |
How this compares
Too few foot & ankle surgery providers in Mississippito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CiclopiroxCiclopirox Olamine | 90 | $2,876 |
| Ammonium Lactate | 63 | $1,179 |
| Ciclopirox | 55 | $1,147 |
| Gentamicin Sulfate | 28 | $1,067 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 28 | $639 |
| Diclofenac Sodium | 15 | $441 |
| Doxycycline Hyclate | 27 | $169 |
| Gabapentin | 44 | $155 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $34 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Jackson
- Lori ReedJackson$28K
- Ashley BlackwellJackson$2K
- Marion LundOxford$46K
- John KoskoHattiesburg$40K
- Jeremy AdamsTupelo$17K
- Daniel RossFlowood$16K
- Judith SmithBiloxi$8K
- Jeffery VanyperenAmory$6K
- Steven GeorgianLucedale$4K
- Richard CukeljCleveland$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.